Industry News
Pharmaceutical Industry News

With reports leaking out…
With reports leaking out of investor discontent, CEO Mike Doustdar opened Novo's Capital Markets Day by acknowledging that the company’s leadership “have to convince” the audience that “there is a bright future for Novo.”
Bayer has decided to offload its…
Bayer has decided to offload its aging cancer drug Stivarga to German compatriot Grünenthal as a potential new competitor from Exelixis nears an FDA decision.
Trump Promotes Program to Reduce Medicaid Drug Prices
Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt
People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adjust.
Journalist-turned-menopause…
Journalist-turned-menopause advocate Tamsen Fadal is using her storytelling skills to bring overlooked menopause conversations into the mainstream.
With longer progression-free…
With longer progression-free survival, Jake Van Naarden, president of Lilly Oncology, told Fierce he expects most patients to choose the combination over oral SERD monotherapy.
U.S. Women Seeking Hormone-Free IUDs Come Up Short
More patients want nonhormonal methods of birth control. Yet only one copper IUD is currently available in the United States.
With many of the healthcare…
With many of the healthcare industry’s top marketing minds converging in the City of Brotherly Love this past week, the galvanizing power of humor, authenticity and a little outside-of-the-box thinking in an ever-changing consumer landscape
The CHMP recommendation for Novo’s…
The CHMP recommendation for Novo's next gen hemophilia A treatment was one of several noteworthy endorsements made by the EU agency this week.
Most drug licensing deals with…
Most drug licensing deals with China will be safe from rules being drafted by the U.S. Treasury Department, Reuters reports. Akeso and Summit's ivonescimab, B7-H3 ADCs and a surprise negative overall survival trend from Enhertu
A.I. Agents as ‘Co-Scientists’? This Lab Says They Could Speed Drug Research.
A.I. is already a powerful tool for scientific discovery. Now, some biomedical researchers are teaching it to do even more.
Ultragenyx scored a belated…
Ultragenyx scored a belated regulatory win with FDA approval for a first-in-disease gene therapy, giving the company a boost after a previous regulatory rejection and a recent late-stage setback.
The heart and kidney med earned…
The heart and kidney med earned the first FDA nod in three decades for adults with chronic kidney disease associated with type 1 diabetes.
How proactive risk management,…
How proactive risk management, transparency and flexible communication can turn a CDMO relationship into a true strategic partnership.
Following the news that longtime…
Following the news that longtime helmsman Paul Chaplin would be hanging up his hat at Bavarian Nordic earlier this year, the Danish vaccine maker has found a CEO replacement whose CV spans leadership roles across
Roche’s T-cell engager portfolio…
Roche’s T-cell engager portfolio has notched another milestone, as a phase 3 trial of the company’s Lunsumio met its primary endpoint in earlier-line follicular lymphoma.
Eli Lilly is marking World…
Eli Lilly is marking World Alzheimer’s Day with a partnership to distribute 13,500 boxes of brain-healthy fresh produce and educational materials to underserved senior populations across the U.S.
Sun Pharma is teaming up with…
Sun Pharma is teaming up with fashion designer Christian Siriano for a new educational campaign focused on the positives of regrowing lost hair.
The comedian sat down with Fierce…
The comedian sat down with Fierce to discuss his health advocacy journey as a type 2 diabetic and his work using comedy and humor to bring light to sight-related diabetes complications in Genentech's "All Eyes
Former Publicis Health Media CEO…
Former Publicis Health Media CEO Andrea Palmer has revealed her next post. The executive has taken the CEO position at Assembled Intelligence, the agency that Minds + Assembly launched last year to integrate its flurry


